Catalyst Pharmaceuticals (CPRX) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and Catalyst Pharmaceuticals (NASDAQ:CPRX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

Do institutionals and insiders believe in ASND or CPRX?

79.2% of Catalyst Pharmaceuticals shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by company insiders. Comparatively, 10.4% of Catalyst Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts rate ASND or CPRX?

Ascendis Pharma A/S presently has a consensus price target of $220.67, suggesting a potential upside of 27.48%. Catalyst Pharmaceuticals has a consensus price target of $32.83, suggesting a potential upside of 53.07%. Given Catalyst Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Catalyst Pharmaceuticals is more favorable than Ascendis Pharma A/S.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
Catalyst Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Is ASND or CPRX more profitable?

Catalyst Pharmaceuticals has a net margin of 36.91% compared to Ascendis Pharma A/S's net margin of -93.22%. Catalyst Pharmaceuticals' return on equity of 42.45% beat Ascendis Pharma A/S's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-93.22%	N/A	-33.29%
Catalyst Pharmaceuticals	36.91%	42.45%	36.59%

Does the media favor ASND or CPRX?

In the previous week, Ascendis Pharma A/S and Ascendis Pharma A/S both had 5 articles in the media. Ascendis Pharma A/S's average media sentiment score of 1.20 beat Catalyst Pharmaceuticals' score of 1.01 indicating that Ascendis Pharma A/S is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Catalyst Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, ASND or CPRX?

Catalyst Pharmaceuticals has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Catalyst Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$393.54M	26.89	-$409.12M	-$6.28	-27.56
Catalyst Pharmaceuticals	$491.73M	5.32	$163.89M	$1.57	13.66

Which has more volatility and risk, ASND or CPRX?

Ascendis Pharma A/S has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, Catalyst Pharmaceuticals has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500.

Summary

Catalyst Pharmaceuticals beats Ascendis Pharma A/S on 12 of the 16 factors compared between the two stocks.